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12R-lipoxygenase (12R-LOX) represents a key enzyme of a recently identified eicosanoid pathway in the skin that
plays an essential role in the establishment and/or maintenance of the epidermal barrier function. Genetic
studies show that loss-of-function mutations in ALOX12B, encoding 12R-LOX, and in ALOXE3, encoding another
closely related LOX involved in this pathway, are the second most common cause for autosomal recessive
congenital ichthyosis (ARCI). To investigate the pathomechanism of ARCI and the function of 12R-LOX, we
recently generated a 12R-LOX knockout model. 12R-LOX-deficient mice die rapidly after birth from severe
barrier dysfunction without exhibiting an obvious cutaneous phenotype. Thus, we analyzed the adult
phenotype of 12R-LOX/ skin transplanted onto nude mice. 12R-LOX/ skin develops an ichthyosiform
appearance with thickening of the epidermis, hyperproliferation, hypergranulosis, focal parakeratosis, and
severe hyperkeratosis. The adult mutant mouse skin phenotype closely reproduces the ichthyosis phenotype
seen in patients with ALOX12B mutations. Western blot analysis revealed restoration of profilaggrin processing
that used to be disturbed in neonatal mutant skin and overexpression of filaggrin, involucrin, and repetin. The
results indicate that 12R-LOX knockout mice may represent a useful animal model for a detailed analysis of
mechanisms involved in ARCI forms that are associated with impaired LOX metabolism.
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INTRODUCTION
Autosomal recessive congenital ichthyoses (ARCI), including
lamellar ichthyosis and nonbullous congenital ichthyosiform
erythroderma form a clinically and genetically heterogeneous
group of severe keratinization disorders that are associated
with impaired skin barrier function (Traupe, 1989; Oji and
Traupe, 2006). It is a severe condition with an estimated
prevalence of one in 200,000 newborns. The disease is
characterized by intense scaling of the whole integument,
different in color and shape, and is sometimes associated
with erythema. Affected individuals are often born as
collodion babies encased in a tough inelastic membrane.
Histological features of the epidermis in ARCI are non-
specific, but typically include a compensatory thickening of
the stratum corneum and epidermal hyperplasia. Ultrastruc-
turally, several types of distinct morphological markers can
be differentiated, part of them corresponding to specific
molecular genetic constellations (Pigg et al., 1998; Akiyama
et al., 2006; Melin et al., 2006; Dahlqvist et al., 2007).
In nonsyndromic ARCI so far, six different genes have been
identified that cause the observed phenotype (Oji and
Traupe, 2006). The corresponding proteins are involved in
the production, transport, or assembly of components of the
stratum corneum that constitutes the permeability barrier of
the skin. TGM1 (OMIM 190195)-encoding transglutaminase
1 is implicated in the crosslinking of structural proteins and
lipids forming the cornified cell envelope. ABCA12 (OMIM
607800) that is mutated in lamellar ichthyosis type 2 and
harlequin ichthyosis encodes a lipid transporter critically
involved in the maturation and secretion of lamellar bodies.
The other recently identified ARCI genes including the
lipoxygenase (LOX) genes ALOX12B (OMIM 603741) and
ALOXE3 (OMIM 607206), a recently identified cytochrom
P450 gene CYP4F22 (OMIM 611495) and a putative receptor
gene ichthyin (OMIM 609383) have been suspected to be
part of a common lipid pathway (Lefevre et al., 2006).
ALOX12B and ALOXE3 encoding 12R-LOX and epider-
mis-type LOX-3 are members of the epidermal subfamily of
mammalian LOX with preferential expression in skin and
several other epithelial tissues (Krieg et al., 2002). LOX
represents a widespread family of nonheme iron dioxy-
genases that insert molecular oxygen into polyunsaturated
fatty acids thus producing highly active lipid mediators
(Brash, 1999). 12R-LOX and epidermis-type LOX-3 differ
from all other LOX by unusual structural and enzymatic
features. 12R-LOX represents the only mammalian LOX that
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forms products with R-chirality and, unlike all other LOX,
epidermis-type LOX-3 does not exhibit dioxygenase activity
but functions as a hydroperoxide isomerase (Kinzig et al.,
1999; Krieg et al., 1999; Yu et al., 2003). Both enzymes act in
sequence to convert arachidonic acid via 12R-hydroperox-
yeicosatetraenoic acid to the corresponding hepoxilin-like
epoxyalcohol, 8R-hydroxy-11R,12R-epoxyeicosatrienoic acid
(Brash et al., 2007).
Mutations in ALOX12B or ALOXE3 have been identified in
about 10% of ARCI patients (Jobard et al., 2002; Eckl et al.,
2005; Lesueur et al., 2007). We and others have shown that
the mutations found completely eliminated the catalytic
activity of the LOX enzymes, indicating that mutational
inactivation of either 12R-LOX or epidermis-type LOX-3 is
causally linked to the ARCI phenotype (Eckl et al., 2005; Yu
et al., 2005).
To analyze the molecular mechanisms that underlie the
ichthyosiform skin phenotype, we recently developed an
animal model with targeted inactivation of the 12R-LOX gene
in mice (Epp et al., 2007). 12R-LOX deficiency in these mice
and similarly in another mouse model harboring a loss-of-
function mutation in Alox12b (Moran et al., 2007) leads to a
postnatal lethal phenotype due to a severely impaired inward
and outward permeability barrier function. Probably because
of their short lifespan 12R-LOX-deficient mice do not develop
a typical ichthyosiform skin phenotype.
In this study, we have analyzed the adult 12R-LOX
knockout phenotype in skin transplants on the back of nude
mice. We show that skin lacking 12R-LOX function develops
an adult phenotype that recapitulates the typical compen-
satory responses to impaired epidermal barrier function
observed in ichthyosis patients including hyperproliferation,
hypergranulosis, and marked hyperkeratosis.
RESULTS
Ichthyosiform phenotype of mature Alox12b-deficient mouse
skin
Macroscopically, Alox12b-deficient neonates do not develop
a gross skin because they die within 3–5 hours after birth
(Epp et al., 2007). As shown in this study, an adult
ichthyosiform phenotype develops in skin from Alox12b/
grafted onto the back of nude mice. At 4 weeks after
transplantation, the grafts were covered with normal hair
(Figure 1a and b). Macroscopically, no significant differences
were apparent between knockout and control grafts. At the
level of hematoxylin/eosin-stained paraffin section images
the histology of control skin grafts on nude mice was similar
to that of normal adult mouse skin with a thin epidermis that
consists of 2–3 nucleated cell layers without visible stratum
granulosum (Figure 1 c). In contrast, skin grafted from
Alox12b-deficient neonates was considerably thicker exhibit-
ing a hyperplastic phenotype with epidermal acanthosis and
pronounced hyperkeratosis (Figure 1d).
Ultrastructural analysis
Electron microscopy confirmed hyperkeratosis at the ultra-
structural level. As compared with control skin grafts, the
stratum corneum of skins grafted from Alox12b-deficient
mice was markedly piled up in over 30 layers (Figure 2a
and b). Of note, lipid droplets and occasionally remnants of
cellular components, e.g, of nuclei were observed in
corneocytes of the mutant skin grafts but not of the control
grafts (Figure 2c and d). In addition, deposits resembling
extruded contents of lamellar bodies in the transient zone
were seen in the intercellular spaces of higher stratum
corneum levels of mutant skin grafts suggesting disturbed
extrusion or processing of lamellar bodies. Furthermore, both
the size and the number of keratohyaline granules were
increased indicating hypergranulosis in mutant skin grafts
(Figure 2b). The characteristic vacuole-like anomalies
observed in the granular layers of neonatal Alox12b-deficient
skin, however, could not be detected in the grafted adult
mutant skin.
Alox12b-deficient skin grafts exhibit a hyperproliferative
phenotype
The epidermal proliferation index of the grafted skin was
determined by immunofluorescence analysis as the percent-
age of Ki67-staining nuclei in the epidermis (Figure 3a and b).
Ki67-positive cells were significantly increased in the mutant
grafts as compared to the control grafts (63.4±3.2% vs
46.4±0.6% in knockout and control mice, respectively),
which indicates a significant hyperproliferation of the epi-
dermis. Although in control grafts, all Ki67-positive cells
remain restricted to the basal cell layer, Ki67-staining nuclei
were occasionally observed in the first suprabasal layer of
mutant skin grafts (Figure 3b). Consistently with epidermal
hyperproliferation, a strong expression of keratin K6 was
observed in basal and suprabasal layers of the mutant skin graft
but only focally in those of control grafts (Figure 3c and d).
Overexpression of CE proteins
The expression of epidermal keratin and terminal differentia-
tion markers in the skin grafts was evaluated by immuno-
fluorescence and western blotting. Basal cell-specific keratin
K14 was present at similar levels showing a comparable
immunostaining pattern in mutant and control skin grafts
(Figure 4a and b). Strong expression of keratin K10 was
observed in all living suprabasal cell layers, but appeared
much broader in the transplants from the Alox12b-deficient
skin (Figure 4c and d). Similarly, proteins of the cornified
envelope (CE) such as involucrin, repetin, and filaggrin were
seen in their typical localizations in both control and mutant
skin grafts, with the consistent difference, however, that
the staining was stronger and the number of cell layers
showing immunostaining of these proteins was higher in the
grafts from Alox12b-deficient mice (Figure 4e–j). Consistently
with these observations, western blot analysis demonstrated
a markedly increased expression of these CE proteins and
K6 in mutant skin grafts as compared to wild-type transplants,
although the levels of K5 and K10 were the similar in both
genotypes (Figure 5a). Most interestingly, in addition to a
strong overexpression of profilaggrin precursor intermediates
also highly increased levels of fully processed filaggrin
monomers were detected that indicates complete profilaggrin
processing in the mutant adult skin grafts in contrast to
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the neonatal Alox12b-deficient skin that previously has been
shown to completely lack mature filaggrin monomers
(Figure 5b).
Increased transepidermal water loss
The barrier function in the transplanted skin was assessed by
measuring transepidermal water loss (TEWL). TEWL in the
grafted control skin was 3.2±0.2 gm2 per hour, a level
similar to that found in normal neonatal skin (2.6±0.2gm2
per hour). The TEWL levels of grafted mature Alox12b-
deficient skin was about threefold higher (7.9±0.3 gm2 per
hour), but significantly reduced as compared to the levels of
Alox12b/ neonates (14.4±0.3 gm2 per hour, (Epp et al.,
2007).
DISCUSSION
Loss-of-function mutations in ALOX12B and ALOXE3 are the
second most common cause for ARCI (Jobard et al., 2002;
Eckl et al., 2005; Lesueur et al., 2007; Harting et al., 2008).
Recently, we have generated Alox12b knockout mice as a
human disease model for ARCI (Epp et al., 2007). Mice with
Alox12b deficiency die rapidly after birth as a result of severe
dehydration. In fact, gene defects that disrupt barrier function
are known to cause a more severe phenotype in the mouse
than in human skin as a result of the much larger surface to
volume ratio. Morphologically, however, the newborn
knockout mice do not exhibit an obvious cutaneous
phenotype.
In this study, we demonstrate that Alox12b-deficient
mouse skin that matures after transplantation onto nude mice
reveals an ichthyosiform appearance with thickening of the
epidermis, hyperproliferation, hypergranulosis, parakeratosis,
and severe hyperkeratosis. These features represent typical
compensatory mechanisms observed in the adult epidermis
of other deficient mice suffering from severe skin barrier
defects and recapitulate the phenotype observed in skin from
ichthyosis patients (Segre, 2003; Oji and Traupe, 2006).
Compensatory pathological epidermal mechanisms such as
these primarily serve to counteract an increased loss of water
through the skin. In fact, presumably as a result of the massive
hyperkeratosis, the TEWL of the adult transplants from
Alox12b-deficient skin is considerably decreased as com-
pared to neonatal knockout skin, but still significantly higher
than in the control skin grafts. Although in many mouse
models with defective barrier function, a cutaneous pheno-
type is already apparent at birth, the development of
hyperplasia and thickening of the stratum corneum in the
12R-LOX knockout skin might represent later response
processes, a feature that was also observed in TGase1-
deficient mice (Kuramoto et al., 2002). Skin grafts from
TGase1/ mice and from other mice with barrier defects,
however, typically show alopecia, marked erythema, and
a b
c d
Control Alox12b –/–
Figure 1. Ichthyosiform phenotype of mature Alox12b-deficient mouse skin. (a, b) Gross morphology shows no differences between control and 12R-LOX/
mouse skin grafted on nude mice for 4 weeks. (c, d) Representative skin sections from control and mutant mouse skin grafts stained with hematoxylin and
eosin. The control skin graft is almost identical to normal adult mouse skin. In contrast, the grafted 12R-LOX/ mouse skin shows epidermal acanthosis and
severe hyperkeratosis. Scale bars¼ 0.1mm.
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massive scales (Furuse et al., 2002; Stone et al., 2004;
Descargues et al., 2005). 12R-LOX knockout grafts, in
contrast, exhibit normal hair growth, no erythema and mild
scaling. This macroscopic appearance closely reproduces the
mild phenotype seen in many patients with ALOX12B
mutations that is characterized by moderate light scaling
with no or moderate erythema (Jobard et al., 2002; Eckl et al.,
2005; Lesueur et al., 2007; Harting et al., 2008). On the other
hand a more severe phenotype with intense lamellar scaling
and large brown scales as well as even a self-healing
collodion baby phenotype (Harting et al., 2008) was
observed in other patients with ALOX12B mutations con-
firming clinical heterogeneity of ARCI. Heterogeneity is also
manifested on the histopathological and even more on the
ultrastuctural level. To date, there are only two reports in the
literature on the morphological features of skin biopsies from
patients with ALOX12B mutations. Histologically, the mouse
skin grafts closely resemble the phenotype of a patient
exhibiting the clinical features of self-healing collodion
membrane (Harting et al., 2008). The skin biopsy taken 3
days after birth at the edge of the collodion membrane
showed a thickened orthokeratotic stratum corneum contain-
ing numerous cytoplasmic droplets and increased promi-
nence of the granular layer with underlying mild acanthosis.
In another report, the histological analyses of two patients
with ALOX12B mutations similarly showed orthokeratotic
hyperkeratosis but reduced or absent stratum granulosum
(Lesueur et al., 2007). Respective studies of our group have
revealed further diversity of the morphological phenotype.
More comprehensive morphological analyses of skin biopsies
from patients with ALOX12B mutations are needed to further
clarify similarities and differences between the Alox12b-
deficient mouse skin and human patient skin.
A characteristic ultrastructural feature of the neonatal
12R-LOX knockout skin is the presence of vacuole-like
structures in the upper granular cells, the appearance of
a b
c d
e
Figure 2. Ultrastructural anomalies in Alox12b deficient skin transplants. Ultrastructure of the grafted skin from control (a, c) and 12R-LOX/ (b, d, e)
neonates. (b) Stratum corneum and stratum granulosum of the grafted mutant skin. Note the markedly piled up cornified cells and the increased size and number
of keratohyalin granules. (d) Lipid droplets (arrows) and nuclear remnants (asterisk) in the stratum corneum. (e) Remnants of cytoplasmatic organelles in the
intercellular space of the stratum corneum. Scale bars (a, b)¼ 10 mm, (c)¼1 mm, (d)¼ 2mm, (e)¼ 50 nm.
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which resembles those functioning as reliable ultrastructural
markers in a distinct group of ARCI patients (Dahlqvist et al.,
2007; Epp et al., 2007). Our suggestion was that loss of
barrier function may be caused by a disturbance of the
normal processing of lamellar bodies that is essential for the
formation of intercellular lipid structures. Consistent with a
pathogenic role of a disturbed lipid metabolism, we
furthermore observed significant alterations in the composi-
tion of ester-bound ceramides in the neonatal knockout skin.
In this study, however, a comprehensive lipid analysis was
not feasible because of the small size of the skin grafts. In
addition, electron microscopic examination of the adult skin
grafts does not reveal any of the above-described vacuole-
like structures suggesting that these might be caused by some
dysfunctional/disruptive and perhaps secondary process
overcome in the transplants possibly by environmental/
compensating effects of the surrounding host tissue but
present after birth in the neonatal skin. We observe, however,
occasionally deposits of cytoplasmatic material within the
intercellular space of the stratum corneum lamellae of mutant
skin grafts, with the same appearance as extruded contents of
lamellar bodies in the transition area supporting the proposed
hypothesis that 12R-LOX deficiency might affect processing
of lamellar bodies.
Another remarkable feature of the adult skin graft as
compared to the newborn mutant skin is a restoration of the
filaggrin processing. As previously shown, 12R-LOX-deficient
newborn skin completely lacks mature filaggrin monomers, a
defect that considerably might contribute to the early
neonatal death. Disturbance of profilaggrin processing is also
observed in several other mouse models with defective
barrier function and in humans a lack of proteolytically
processed filaggrin monomers has been shown to underlie
ichthyosis vulgaris and suggested to be a major predisposing
factor for atopic dermatitis (Presland et al., 2000; List et al.,
2002; Descargues et al., 2005; Leyvraz et al., 2005; Sandi-
lands et al., 2006; Smith et al., 2006). The processing of
profilaggrin to filaggrin and the final proteolytic steps of
filaggrin degradation is a complex and yet poorly understood
cascade during late differentiation that requires the coordi-
nated activity of various enzymes including phosphatases,
proteases, and protease inhibitors. In which way, any of these
steps is affected by 12R-LOX deficiency is currently
unknown. The reappearance of filaggrin monomers in adult
skin grafts could possibly be explained by a diffusible host
factor that compensates for the defect evoked by 12R-LOX
deficiency in the neonatal knockout skin.
Western blot analysis not only indicated unimpaired
profilaggrin processing in the adult knockout skin grafts but
also, as compared to control grafts, a strong overexpression of
filaggrin and two other CE proteins, involucrin, and repetin,
whereas keratin expression was unchanged. Involucrin
represents a major CE scaffold protein while repetin, another
member of the multifunctional fused gene family profilaggrin
belongs to, is a minor structural CE component commonly
expressed in toughened epithelia and during wound healing
(Krieg et al., 1997; Cooper et al., 2005). Compensatory
upregulation of repetin in response to barrier disturbance has
earlier been observed in the skin of loricrin-deficient mice
(Koch et al., 2000). The genes of filaggrin, involucrin, and
repetin are localized close together within the highly
conserved epidermal differentiation complex, suggesting a
coordinate upregulation of these genes. Such a coordinated
upregulation of genes within the epidermal differentiation
complex has been reported from mice with targeted ablation
of the transcription factor klf4 where 12 of the 15 members of
Control
Ki67 Ki67
K6K6
a b
c d
AIox12b–/–
Figure 3. Hyperproliferative phenotype of mature Alox12b-deficient mouse skin. Immunofluorescence on (a, c) control and (b, d) 12R-LOX/ skin grafts
shows an increased number of Ki67-positive nuclei (b) and strong upregulation of keratin K6 throughout the epidermis (d) in mutant grafts. Nuclei are
counterstained with Hoechst 33258. The dashed line shows the epidermal/dermal junction. Scale bars (a, b)¼ 20mm, (c, d)¼ 25mm.
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the small proline-rich protein gene family (sprr) were found to
be upregulated in response to the severe barrier dysfunction
in these mice (Patel et al., 2003). It remains to be evaluated
whether the expression of sprr and/or other genes of the
epidermal differentiation complex is misregulated in 12R-
LOX-deficient skin in a similar manner.
In summary, this study shows that mature 12R-LOX-
deficient mouse skin develops an ichthyosiform phenotype
that closely resembles the phenotype observed in ichthyosis
patients indicating that 12R-LOX knockout mice represent a
suitable animal model for ARCI forms associated with an
impaired LOX metabolism. Work is currently in progress on a
K14
a
c d
e f
g h
i j
K14
K10K10
Flg Flg
RptRpt
Inv Inv
b
Control Alox12b–/–
Figure 4. Analysis of epidermal differentiation markers in transplanted skin from control and Alox12b-deficient mice. Grafted skin sections from control (left
panel) and Alox12b-deficient mice (right panel) were immunostained for the indicated epidermal differentiation markers. Nuclei are counterstained with
Hoechst 33258. (a, b) Immunostaining of keratin 14 is seen in similar levels at the basal layer. (c, d) Keratin 10, (e, f) filaggrin, (g, h) repetin, and (i, j) involucrin
staining are found in their typical localizations in control as well as in mutant skin grafts but appeared broader in the transplants from deficient skin. Scale bars
(a–j)¼ 20 mm.
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more comprehensive analysis of the adult 12R-LOX-deficient
skin phenotype by using a refined conditional knockout
model with inducible keratinocyte-specific gene inactivation
in which the molecular mechanisms of LOX action and the
pathomechanisms of ichthyosis as well as future putative
therapeutic approaches can be investigated.
MATERIALS AND METHODS
Animals
The animal experiments were performed in accordance with the
guidelines of the Arbeitsgemeinschaft der Tierschutzbeauftragten in
Baden-Wu¨rttemberg (Officials for Animal Welfare) and were
approved by the Regierungspra¨sidium Karlsruhe, Germany. All
animals used for this study were kept at the central animal facility
of the German Cancer Research Center. Animals were maintained
under pathogen-free conditions, an artificial day/night rhythm and
were feed standard food pellets (Altromin, Lage, Germany), with
sterile water available ad libitum.
Alox12b/ mice were generated by intercrossing of hetero-
zygous mutant mice and genotyping was performed by PCR as
described previously (Epp et al., 2007).
Skin grafting
In total, 17 control and 15 Alox12b/ newborn were killed by
decapitation, and their dorsal skins were excised and transplanted onto
nude mice using a slightly modified skin-flap technique (Barrandon et al.,
1988). Those grafted skins were fully adapted within 2 weeks of grafting.
At 4 weeks after transplantation they were harvested for the analysis.
Antibodies
Mouse monoclonal anti-12R-LOX antibody has been described
earlier (Epp et al., 2007). Other primary antibodies used were mouse
anti-GAPDH (Santa Cruz Biotechnology, Heidelberg, Germany),
mouse anti-filaggrin (Abcam, Cambridge, UK), rabbit anti-repetin,
rabbit anti-keratin 5, rabbit anti-keratin 10, rabbit anti-involucrin,
guinea pig anti-keratin 14 (all BabCo, Richmond, CA),
mouse anti-Ki67 (Innovative Diagnostik-Systeme, Hamburg,
Germany), and mouse anti-keratin 6 (Covance, Princeton, NJ).
Secondary antibodies were Alexa Fluor 488 goat anti-mouse IgG
(Invitrogen, Karlsruhe, Germany), CY3 anti-rabbit IgG (BD Bios-
ciences, Heidelberg, Germany), CY3 anti-guinea pig (Jackson
ImmunoResearch, Suffolk, UK), anti-goat antibodies (Santa Cruz
Biotechnology), and horseradish peroxidase-conjugated anti-rabbit
(BD Biosciences).
Epidermal protein extraction and Western blot analysis
Skin was extended on paper and immediately frozen in liquid
nitrogen. Epidermis was mechanically separated from the dermis by
scratching. Then epidermis was homogenized in ice-cold lysis buffer
containing 1% TritonX-100, 0.5% deoxycholate, 0.1% SDS, 2mM
EDTA, 10% Glycerol, 150mM NaCl, 50mM Tris, pH 7.4, and protein
inhibitors (1mM phenylmethanesulphonylfluoride, aprotinin
1mgml1, and leupeptin 1mgml1). Western blot analysis was
performed as previously described (Epp et al., 2007).
Histological and immunohistochemical analysis
For light microscopic observation, samples were fixed for 24 h with
4% formalin in phosphate-buffered saline (PBS), dehydrated in 70%
ethanol, and then embedded in paraffin. Five-mm sections were
mounted on slides, dewaxed, rehydrated, and stained with
hematoxylin/eosin. For immunofluorescence microscopy, 5-mm
cryosections were fixed in acetone for 10minutes at 20 1C and
then permeabilized with 0.05% Triton X-100 in PBS and flushed
with PBS. The slides were blocked in 1% BSA in PBS for 1 h and then
incubated with the primary antibody for 1 h. After washing three
times (10minutes each) in PBS, samples were incubated with a
fluorescent dye-coupled antibody and Hoechst 33258 diluted in
blocking buffer for 30minutes and washed as described above.
Sections were embedded in mounting medium (DakoCytomation,
Hamburg, Germany) and examined by light microscopy using a
photomicroscope (Zeiss Axioplan2, Go¨ttingne, Germany) with
a Zeiss  25 Plan-Neofuar objective. Images were acquired with a
high sensibility digital black/white AxioCam (Zeiss).
Measurement of transepidermal water loss
The rate of TEWL from the skin transplants was determined using a
Tewameter (Courage and Khazaka, Cologne, Germany) under
normal conditions. Data are expressed in gm2 per hour.
Electron microscopy
All specimens were fixed for at least 2 h at room temperature in
3% glutaraldehyde solution in 0.1. cacodylate buffer, pH 7.4, cut
into pieces of B1mm3, washed in buffer, postfixed for 1 h at 41
in 1% osmium tetroxide, rinsed in water, dehydrated through
graded ethanol solutions, transferred into propylene oxide, and
embedded in epoxy resin (glycidether 100). Ultrathin sections
were cut with an ultramicrotome (Reichert Ultracut E, Depew, NY),
treated with uranyl acetate and lead citrate, and examined
with an electron microscope (Philips EM 400, Eindhoven, The
Netherlands).
kDa
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Figure 5. Unimpaired filaggrin processing and upregulation of CE proteins in
mature Alox12b-deficient mouse skin. Equal amounts of epidermal protein
extracts from control (þ /þ ) and homozygous mutant (/) skin graft were
separated through SDS–PAGE and subjected to western blot analysis using
specific antibodies against (a) involucrin (Inv), repetin (Rptn), keratin 6 (K6),
keratin 10 (K10), keratin 5 (K5), glycerol-aldehyd-3-phosphat-dehydrogenase
(GAPDH), and (b) filaggrin (Fil).
www.jidonline.org 1435
Silvia de Juanes et al.
Alox12b-Deficient Mouse Skin Transplants
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Cornelia Hasenknopf, Renate Ayubi, Christiane Gropengieber-Forg,
and Heinrich Steinbauer for excellent technical assistance and Wilhelm
Stoffel for providing the Tewameter. This work was supported by grants from
the Deutsche Forschungsgemeinschaft (KR 905/6-1) and from the German
BMBF (NIRK, 01GM0610).
REFERENCES
Akiyama M, Sakai K, Wolff G, Hausser I, McMillan JR, Sawamura D et al.
(2006) A novel ABCA12 mutation 3270delT causes harlequin ichthyosis.
Br J Dermatol 155:1064–6
Barrandon Y, Li V, Green H (1988) New techniques for the grafting of
cultured human epidermal cells onto athymic animals. J Invest Dermatol
91:315–8
Brash AR (1999) Lipoxygenases: occurrence, functions, catalysis, and
acquisition of substrate. J Biol Chem 274:23679–82
Brash AR, Yu Z, Boeglin WE, Schneider C (2007) The hepoxilin connection in
the epidermis. FEBS J 274:3494–502
Cooper L, Johnson C, Burslem F, Martin P (2005) Wound healing and
inflammation genes revealed by array analysis of ‘macrophageless’ PU.1
null mice. Genome Biol 6:R5
Dahlqvist J, Klar J, Hausser I, nton-Lamprecht I, Pigg MH, Gedde-Dahl T Jr
et al. (2007) Congenital ichthyosis: mutations in ichthyin are associated
with specific structural abnormalities in the granular layer of epidermis.
J Med Genet 44:615–20
Descargues P, Deraison C, Bonnart C, Kreft M, Kishibe M, Ishida-Yamamoto
A et al. (2005) Spink5-deficient mice mimic Netherton syndrome
through degradation of desmoglein 1 by epidermal protease hyperactiv-
ity. Nat Genet 37:56–65
Eckl KM, Krieg P, Kuster W, Traupe H, Andre F, Wittstruck N et al. (2005)
Mutation spectrum and functional analysis of epidermis-type lipoxy-
genases in patients with autosomal recessive congenital ichthyosis. Hum
Mutat 26:351–61
Epp N, Furstenberger G, Muller K, de JS, Leitges M, Hausser I et al. (2007)
12R-lipoxygenase deficiency disrupts epidermal barrier function. J Cell
Biol 177:173–82
Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y et al. (2002)
Claudin-based tight junctions are crucial for the mammalian epidermal
barrier: a lesson from claudin-1-deficient mice. J Cell Biol 156:1099–111
Harting M, Brunetti-Pierri N, Chan CS, Kirby J, Dishop MK, Richard G et al.
(2008) Self-healing collodion membrane and mild nonbullous congenital
ichthyosiform erythroderma due to 2 novel mutations in the ALOX12B
gene. Arch Dermatol 144:351–6
Jobard F, Lefevre C, Karaduman A, Blanchet-Bardon C, Emre S, Weissenbach J
et al. (2002) Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase
(ALOX12B) are mutated in non-bullous congenital ichthyosiform
erythroderma (NCIE) linked to chromosome 17p13.1. Hum Mol Genet
11:107–13
Kinzig A, Heidt M, Fu¨rstenberger G, Marks F, Krieg P (1999) cDNA cloning,
genomic structure and chromosomal localization of a novel murine
epidermis-type lipoxygenase. Genomics 58:158–64
Koch PJ, de Viragh PA, Scharer E, Bundman D, Longley MA, Bickenbach J
et al. (2000) Lessons from loricrin-deficient mice: compensatory
mechanisms maintaining skin barrier function in the absence of a major
cornified envelope protein. J Cell Biol 151:389–400
Krieg P, Heidt M, Siebert M, Kinzig A, Marks F, Furstenberger G (2002)
Epidermis-type lipoxygenases. Adv Exp Med Biol 507:165–70
Krieg P, Schuppler M, Koesters R, Mincheva A, Lichter P, Marks F (1997)
Repetin (Rptn), a new member of the ‘‘fused gene’’ subgroup within the
S100 gene family encoding a murine epidermal diffrerentiation protein.
Genomics 43:339–48
Krieg P, Siebert M, Kinzig A, Bettenhausen R, Marks F, Fu¨rstenberger G (1999)
Murine 12(R)-lipoxygenase: functional expression, genomic structure
and chromosomal localization. FEBS Lett 446:142–8
Kuramoto N, Takizawa T, Takizawa T, Matsuki M, Morioka H, Robinson JM
et al. (2002) Development of ichthyosiform skin compensates for
defective permeability barrier function in mice lacking transglutaminase
1. J Clin Invest 109:243–50
Lefevre C, Bouadjar B, Ferrand V, Tadini G, Megarbane A, Lathrop M et al.
(2006) Mutations in a new cytochrome P450 gene in lamellar ichthyosis
type 3. Hum Mol Genet 15:767–76
Lesueur F, Bouadjar B, Lefevre C, Jobard F, Audebert S, Lakhdar H et al.
(2007) Novel mutations in ALOX12B in patients with autosomal
recessive congenital ichthyosis and evidence for genetic heterogeneity
on chromosome 17p13. J Invest Dermatol 127:829–34
Leyvraz C, Charles RP, Rubera I, Guitard M, Rotman S, Breiden B et al. (2005)
The epidermal barrier function is dependent on the serine protease
CAP1/Prss8. J Cell Biol 170:487–96
List K, Haudenschild CC, Szabo R, Chen W, Wahl SM, Swaim W et al. (2002)
Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier
function, hair follicle development, and thymic homeostasis. Oncogene
21:3765–79
Melin M, Klar J Jr, Gedde-Dahl T, Fredriksson R, Hausser I, Brandrup F et al.
(2006) A founder mutation for ichthyosis prematurity syndrome restricted
to 76 kb by haplotype association. J Hum Genet 51:864–71
Moran JL, Qiu H, Turbe-Doan A, Yun Y, Boeglin WE, Brash AR et al. (2007)
A mouse mutation in the 12R-lipoxygenase, Alox12b, disrupts
formation of the epidermal permeability barrier. J Invest Dermatol
127:1893–7
Oji V, Traupe H (2006) Ichthyoses: differential diagnosis and molecular
genetics. Eur J Dermatol 16:349–59
Patel S, Kartasova T, Segre JA (2003) Mouse Sprr locus: a tandem array of
coordinately regulated genes. Mamm Genome 14:140–8
Pigg M, Gedde-Dahl T Jr, Cox D, Hausser I, Anton-Lamprecht I, Dahl N
(1998) Strong founder effect for a transglutaminase 1 gene mutation in
lamellar ichthyosis and congenital ichthyosiform erythroderma from
Norway. Eur J Hum Genet 6:589–96
Presland RB, Boggess D, Lewis SP, Hull C, Fleckman P, Sundberg JP (2000)
Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an
animal model for the filaggrin-deficient skin disease ichthyosis vulgaris.
J Invest Dermatol 115:1072–81
Sandilands A, O’Regan GM, Liao H, Zhao Y, Terron-Kwiatkowski A, Watson
RM et al. (2006) Prevalent and rare mutations in the gene encoding
filaggrin cause ichthyosis vulgaris and predispose individuals to atopic
dermatitis. J Invest Dermatol 126:1770–5
Segre J (2003) Complex redundancy to build a simple epidermal permeability
barrier. Curr Opin Cell Biol 15:776–82
Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao
Y et al. (2006) Loss-of-function mutations in the gene encoding filaggrin
cause ichthyosis vulgaris. Nat Genet 38:337–42
Stone SJ, Myers HM, Watkins SM, Brown BE, Feingold KR, Elias PM et al.
(2004) Lipopenia and skin barrier abnormalities in DGAT2-deficient
mice. J Biol Chem 279:11767–76
Traupe H (1989) In: The Ichthyosis. A Guide to Clinical Diagnosis, Genetic
Counseling, and Therapy. (Traupe H ed) Berlin: Springer, 111–34
Yu Z, Schneider C, Boeglin WE, Brash AR (2005) Mutations associated with a
congenital form of ichthyosis (NCIE) inactivate the epidermal lipox-
ygenases 12R-LOX and eLOX3. Biochim Biophys Acta 1686 3:238–47
Yu Z, Schneider C, Boeglin WE, Marnett LJ, Brash AR (2003) The
lipoxygenase gene ALOXE3 implicated in skin differentiation
encodes a hydroperoxide isomerase. Proc Natl Acad Sci USA 100:
9162–7
1436 Journal of Investigative Dermatology (2009), Volume 129
Silvia de Juanes et al.
Alox12b-Deficient Mouse Skin Transplants
